IR-MED Inc. has recently released an amendment to its management certification for the financial results ending December 31, 2024. This update, requested by OTC Markets Group, is a restatement of the original publication made on May 12, 2025. The company confirms that the information provided is accurate and complete to the best of its knowledge. The restated document highlights IR-MED Inc.'s compliance with SEC reporting obligations and other regulatory requirements. Additionally, the company maintains its commitment to timely disclose material information in line with U.S. federal securities laws. IR-MED Inc. assures stakeholders of its good standing and organized structure under the relevant jurisdictional laws.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.